DAVID MOATAZEDI, CEO & President, Director at Evolus, holds 673.56K shares in Evolus (Ticker: EOLS), holds 83.62K shares in ReShape Lifesciences (Ticker: RSLS), holds 0.00 shares in Biomerica (Ticker: BMRA). Most recently, DAVID MOATAZEDI Sold ― shares of Evolus on May 14, 2024 for an estimated value of 204.01K.